News
February 10, 2011 – A Phase 2 clinical trial has been initiated to test the safety and efficacy of drug to reverse heparin in patients undergoing percutaneous coronary intervention (PCI). The trial will assess PolyMedix’s heptagonist, PMX-60056, a synthetic small-molecule designed to reverse the anticoagulation activity of heparin and low molecular weight heparins (LMWH).
February 10, 2011
News
February 9, 2011 – The first patients have been enrolled in a trial investigating the safety and efficacy of a system that removes clot from acute ischemic stroke patients. The Trevo 2 study will look at the Trevo Retriever device, from Concentric Medical. It is the first device to use Stentriever technology for retrieving clots from the neurovasculature.
February 09, 2011
Technology
February 9, 2011 – The U.S. Food and Drug Administration (FDA) granted 510(k) clearance for enhanced software that automatically detects significant (50 percent and more) stenotic lesions in coronary arteries from coronary computed tomography angiography (CTA) studies. The COR Analyzer system, from Rcadia Medical Imaging, is designed to help speed detection of coronary artery disease.
February 09, 2011Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
February 9, 2011 – The U.S. District Court for the District of Delaware reaffirmed an April 2010 federal jury decision that determined Medtronic CoreValve LLC willfully infringed Edwards Lifesciences' U.S. Andersen transcatheter heart valve patent and awarded Edwards $74 million in damages.
February 09, 2011News
February 9, 2011 – The U.S. Food and Drug Administration (FDA) said certain lots of the Arstasis One femoral artery access system are part of a Class 1 recall. Components of the device may fracture and/or separate during use, which may result in patient harm, the FDA said.
February 09, 2011
News
February 9, 2011 – A partnership has been formed to launch a portable therapeutic cooling system in Europe. Physio-Control and BeneChill will work together to launch the RhinoChill IntraNasal Cooling System, a noninvasive system for transnasally lowering the body’s core temperature immediately following cardiac arrest, stroke or traumatic brain injury
February 09, 2011Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
Technology
February 9, 2011 – The U.S. Food and Drug Administration (FDA) approved the first pacemaker in the United States specifically designed for use in an magnetic resonance imaging (MRI) environment and approved as MRI-conditional. Medtronic said its Revo MRI SureScan pacing system is available immediately.
February 09, 2011
Feature | Dave Fornell
Interoperability is key to the meaningful use and sharing of patients’ electronic images and information.
February 08, 2011
News
February 8, 2011 – The U.S. Food and Drug Administration (FDA) said Merit Medical Systems initiated a Class I recall for one lot of its Prelude Short Sheath Introducer, because the tips may detach during use. The company said a detached tip may cause arterial injury, hemorrhaging or other serious events, or may enter into the bloodstream, causing blood clots.
February 08, 2011Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
News
February 8, 2011 – Researchers at the University of Southern California have developed an algorithm to produce animated magnetic resonance imaging (MRI) scans of body parts or organs in motion. Volume scans of human bodies have a variety of uses in medical diagnosis and research; however, these scans usually do not show the body in movement.
February 07, 2011
Technology
February 7, 2011 – A new positioning system has been launched that is used in performing off- pump coronary artery bypass (OPCAB) procedures on coronary artery bypass graft (CABG) patients.
February 07, 2011News
February 7, 2011 – There is a tremendous unmet need for new medical technologies to treat potentially dangerous chronic venous insufficiency (CVI) and blood clots, according to a Scientia Advisors review of the vascular device market.
February 07, 2011Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023News
February 7, 2011 – A rare and often underreported form of stroke involving veins instead of arteries is more common than previously thought, according to the American Heart Association's (AHA) first scientific statement on diagnosing and managing cerebral venous thrombosis (CVT).
February 07, 2011
News
February 7, 2011 – Final testing for a point-of-care blood analyzer will begin at four hospitals in North America. The QL Care (QLCA) analyzer, by CardioGenics, tests for troponin-I levels, and data will be used to file a 510(k) application with the U.S. Food and Drug Administration (FDA).
February 07, 2011News
February 4, 2011 – In the largest group of emergency department patients with atrial flutter studied to date, researchers found these patients may be substantially different from those described in the cardiology literature. The results of the study were published in the Annals of Emergency Medicine.
February 04, 2011© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now